GeneBioTech Co. Ltd (086060) — Capital Reinvestment Ratio
Latest as of September 2025:
0.05x
GeneBioTech Co. Ltd (086060) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.87 Billion) in capital expenditures (₩194.03 Million). See GeneBioTech Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.87 Billion
KRW
Capital Expenditures
₩194.03 Million
KRW
Data as of
Sep 2025
Most recent filing
GeneBioTech Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks GeneBioTech Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for GeneBioTech Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for GeneBioTech Co. Ltd from 2009 to 2023. For live market cap and broader valuation context, see market cap of GeneBioTech Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.10x | ₩7.37 Billion | ₩766.93 Million | ▼ -94.1% |
| 2020 | 1.76x | ₩2.49 Billion | ₩4.39 Billion | ▲ +1777.2% |
| 2018 | 0.09x | ₩5.96 Billion | ₩558.47 Million | ▼ -90.4% |
| 2017 | 0.98x | ₩1.13 Billion | ₩1.11 Billion | ▲ +300.8% |
| 2016 | 0.24x | ₩5.31 Billion | ₩1.30 Billion | ▼ -31.5% |
| 2015 | 0.36x | ₩2.61 Billion | ₩927.06 Million | ▲ +50.2% |
| 2014 | 0.24x | ₩2.15 Billion | ₩510.55 Million | ▼ -3.2% |
| 2013 | 0.24x | ₩2.38 Billion | ₩582.01 Million | ▼ -75.4% |
| 2011 | 0.99x | ₩2.53 Billion | ₩2.51 Billion | ▲ +66.9% |
| 2010 | 0.60x | ₩1.17 Billion | ₩693.45 Million | ▲ +593.8% |
| 2009 | 0.09x | ₩2.68 Billion | ₩229.99 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow